Da‐Wei Yeh

Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities

Fracture healing: mechanisms and interventions

Osteoporosis: now and the future

WNT signaling in bone homeostasis and disease: from human mutations to treatments

Inflammation and tumor progression: signaling pathways and targeted intervention

Wnt signaling as a therapeutic target for bone diseases

Sclerostin: how human mutations have helped reveal a new target for the treatment of osteoporosis

Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis

DAMP-TLR-cytokine axis dictates the fate of tumor

Update on Bone Anabolics in Osteoporosis Treatment: Rationale, Current Status, and Perspectives

The role of Dickkopf-1 in bone development, homeostasis, and disease

Sclerostin and Dickkopf-1 as Therapeutic Targets in Bone Diseases

DAMP-sensing receptors in sterile inflammation and inflammatory diseases

Inhibition of glycogen synthase kinase-3β attenuates glucocorticoid-induced bone loss

Interplay between Inflammation and Stemness in Cancer Cells: The Role of Toll-Like Receptor Signaling

Modulation of Dickkopf-1 Attenuates Glucocorticoid Induction of Osteoblast Apoptosis, Adipocytic Differentiation, and Bone Mass Loss